We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
3M
MMM
$87.5B
| $87K | 0.13% |
529
-1,826
| -78% | -$312K |
|
102
Air Products & Chemicals
APD
$65.5B
| $86K | 0.13% |
554
-2,290
| -81% | -$374K |
|
103
Best Buy
BBY
$17.8B
| $86K | 0.13% |
1,149
-606
| -35% | -$44.8K |
|
104
Genuine Parts
GPC
$16.5B
| $86K | 0.13% |
+942
| New | +$85.9K |
|
105
Nasdaq
NDAQ
$51.1B
| $86K | 0.13% |
+2,832
| New | +$85.1K |
|
106
John Wiley & Sons Class A
WLY
$2.47B
| $85K | 0.13% |
1,361
-1,822
| -57% | -$121K |
|
107
Ross Stores
ROST
$74.6B
| $84K | 0.13% |
993
-1,675
| -63% | -$136K |
|
108
Goodyear
GT
$2.02B
| $79K | 0.12% |
3,371
+956
| +40% | +$24.6K |
|
|
109
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
| $78K | 0.12% |
933
-106,000
| -99% | -$8.78M |
|
110
Alcoa
AA
$11.9B
| $77K | 0.12% |
+1,643
| New | +$82.6K |
|
111
Agilent Technologies
A
$39.5B
| $76K | 0.12% |
1,224
-1,804
| -60% | -$118K |
|
|
FISV
112
Fiserv Inc
FISV
$26.6B
| $76K | 0.12% |
1,021
-3,317
| -76% | -$241K |
|
113
TJX Companies
TJX
$170B
| $76K | 0.12% |
1,588
-8,946
| -85% | -$393K |
|
114
US Bancorp
USB
$98.7B
| $76K | 0.12% |
1,511
-3,008
| -67% | -$153K |
|
115
Visa
V
$669B
| $76K | 0.12% |
572
-1,138
| -67% | -$146K |
|
116
Atmos Energy
ATO
$29.7B
| $75K | 0.11% |
+837
| New | +$72.5K |
|
117
Costco
COST
$411B
| $75K | 0.11% |
358
-1,975
| -85% | -$390K |
|
118
Cintas
CTAS
$81.3B
| $75K | 0.11% |
+1,620
| New | +$72.9K |
|
119
Estee Lauder
EL
$28.9B
| $75K | 0.11% |
+523
| New | +$77.4K |
|
120
Graham Holdings Company
GHC
$4.92B
| $75K | 0.11% |
+128
| New | +$76.8K |
|
121
Alphabet (Google) Class A
GOOGL
$3.88T
| $75K | 0.11% |
1,320
-2,660
| -67% | -$145K |
|
122
HCA Healthcare
HCA
$83.6B
| $75K | 0.11% |
+729
| New | +$73.8K |
|
123
HP
HPQ
$22.4B
| $75K | 0.11% |
3,296
-12,234
| -79% | -$273K |
|
124
Kilroy Realty
KRC
$4.46B
| $75K | 0.11% |
989
-1,934
| -66% | -$142K |
|
125
Microsoft
MSFT
$2.83T
| $75K | 0.11% |
761
-1,508
| -66% | -$146K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.